GSK3772701

N/A

Report date: 2026/04/23 20:00:25
NME

Base Information

Drug NameGSK3772701
Drug Alias NameMMV-1582367MMV-367GSK-3772701GSK701
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcyl-CoA synthetase inhibitors
TargetsAcyl-CoA synthetase
Therapy Area/IndicationsSystemic Inflammatory Response SyndromeInflammationPathologic Processes +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedicines for Malaria Venture
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcMedicines for Malaria Venture
Inactive CompaniesN/A
Active IndicationsSystemic Inflammatory Response SyndromeInflammationPathologic Processes +[9] 
Inactive IndicationsInfections

Other Information

ATC CodeN/A
Related LinksN/A